LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 49 filers reported holding LARIMAR THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,797,250 | -31.6% | 455,000 | -45.8% | 0.01% | -37.5% |
Q2 2023 | $2,626,070 | +27.4% | 839,000 | +84.4% | 0.01% | +33.3% |
Q1 2023 | $2,061,150 | +5.1% | 455,000 | -4.2% | 0.01% | -14.3% |
Q4 2022 | $1,961,750 | +29.1% | 475,000 | 0.0% | 0.01% | +16.7% |
Q3 2022 | $1,520,000 | -28.5% | 475,000 | +141.2% | 0.01% | -25.0% |
Q4 2021 | $2,125,000 | -6.4% | 196,896 | 0.0% | 0.01% | -20.0% |
Q3 2021 | $2,270,000 | +133.1% | 196,896 | +98.6% | 0.01% | +150.0% |
Q2 2021 | $974,000 | +286.5% | 99,160 | +474.5% | 0.00% | +300.0% |
Q1 2021 | $252,000 | -31.9% | 17,260 | 0.0% | 0.00% | -50.0% |
Q4 2020 | $370,000 | +41.2% | 17,260 | 0.0% | 0.00% | +100.0% |
Q3 2020 | $262,000 | +18.0% | 17,260 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $222,000 | – | 17,260 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 3,473,366 | $14,345,001 | 3.82% |
Opaleye Management Inc. | 1,560,000 | $6,442,800 | 2.24% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,941,357 | $69,967,804 | 1.45% |
GREAT POINT PARTNERS LLC | 1,273,635 | $5,260,113 | 1.03% |
DAFNA Capital Management LLC | 473,136 | $1,954,052 | 0.55% |
COMMODORE CAPITAL LP | 750,000 | $3,098 | 0.47% |
Cheyne Capital Management (UK) LLP | 63,680 | $262,998 | 0.46% |
Atlas Venture Advisors, Inc. | 292,184 | $1,206,720 | 0.42% |
Perceptive Advisors | 2,860,000 | $11,811,800 | 0.33% |
MANGROVE PARTNERS IM, LLC | 1,292,812 | $5,339,314 | 0.30% |